All manufacturing activities at Indian Pharma company Marion Biotech Pvt Ltd have been stopped following allegations by Uzbekistan that at least 18 children died in the country after consuming the medicine.
The manufacturing activities have been stopped after the inspection by the Central Drugs Standard Control Organisation (CDSCO). A joint inspection of the manufacturer’s Noida facility was carried out by the teams of the Uttar Pradesh Drug Control Department and CDSCO.
“Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing”, said Union Health Minister Mansukh Mandaviya in a tweet on Friday.
However, the further investigation is in progress by the government agencies. The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.
Patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts…
As the air pollution levels spike and reached alarming levels in many cities across the…
Highlighting that Antimicrobial Resistance is a global health threat, the Minister of State for health…
SFI Green Heartfulness Run was held on November 17, 2024 at Indirapuram starting from Habitat…
The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…
Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…